Compare HNVR & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HNVR | TKNO |
|---|---|---|
| Founded | 2008 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 147.6M | 138.1M |
| IPO Year | 2022 | 2021 |
| Metric | HNVR | TKNO |
|---|---|---|
| Price | $21.51 | $2.70 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $24.50 | N/A |
| AVG Volume (30 Days) | 4.2K | ★ 131.6K |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.88% | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | ★ 1.00 | N/A |
| Revenue | N/A | ★ $40,520,000.00 |
| Revenue This Year | $35.49 | $8.27 |
| Revenue Next Year | $8.61 | $13.13 |
| P/E Ratio | $21.29 | ★ N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $18.31 | $1.91 |
| 52 Week High | $24.36 | $7.48 |
| Indicator | HNVR | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 45.59 | 49.36 |
| Support Level | $20.44 | $1.97 |
| Resistance Level | $22.41 | $5.39 |
| Average True Range (ATR) | 0.51 | 0.25 |
| MACD | 0.12 | 0.02 |
| Stochastic Oscillator | 53.23 | 34.55 |
Hanover Bancorp Inc is a United States-based banking company. It offers a full range of financial services and employs a complete suite of consumer and commercial banking products and services, including multi-family and commercial mortgages, residential loans, business loans, and lines of credit.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.